AI Engines For more Details: Perplexity Kagi Labs You
Energy Production: NADH is involved in the production of adenosine triphosphate (ATP), the primary energy currency of cells. Some studies suggest that NADH supplementation may help improve energy levels and combat fatigue.
Neurodegenerative Diseases: Research has explored the potential benefits of NADH in neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease. NADH may have neuroprotective effects and could potentially slow the progression of these conditions, although more research is needed.
Mental Health: There is some evidence to suggest that NADH supplementation may have benefits for mental health conditions such as depression and anxiety. NADH is involved in neurotransmitter synthesis and cellular energy production, both of which are relevant to mental health.
Chronic Fatigue Syndrome: Some studies have investigated the use of NADH supplementation in chronic fatigue syndrome (CFS) and fibromyalgia. While results have been mixed, some individuals with these conditions report improvements in energy levels and overall well-being with NADH supplementation.
Athletic Performance: NADH has been marketed as a potential ergogenic aid, with claims that it can improve athletic performance and endurance by enhancing energy metabolism. However, evidence supporting these claims is limited and inconsistent.
Anti-Aging: NADH has been investigated for its potential anti-aging properties, as it is involved in cellular repair processes and may help protect against oxidative stress. Some research suggests that NADH supplementation could have anti-aging effects, but more studies are needed to confirm these findings.
Cardiovascular Health: Preliminary research suggests that NADH may have benefits for cardiovascular health by improving endothelial function and reducing oxidative stress. However, more research is needed to fully understand the impact of NADH supplementation on heart health.
| Rank | Probiotic | Impact |
|---|---|---|
| species | Acinetobacter calcoaceticus | Reduces |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
| Taxonomy | Rank | Effect | Citations | Notation |
|---|---|---|---|---|
| Acinetobacter calcoaceticus | species | Decreases | 📓 Source Study | |
| Acinetobacter calcoaceticus/baumannii complex | species group | Decreases | 👪 Source Study |
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
| Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
|---|---|---|---|
| Chronic Obstructive Pulmonary Disease (COPD) | 0.5 | 0.5 | |
| Multiple Sclerosis | 0.3 | 0.3 |
